Prével, R.; Delmas, Y.; Guillotin, V.; Gruson, D.; Rivière, E.
Complement Blockade Is a Promising Therapeutic Approach in a Subset of Critically Ill Adult Patients with Complement-Mediated Hemolytic Uremic Syndromes. J. Clin. Med. 2022, 11, 790.
https://doi.org/10.3390/jcm11030790
AMA Style
Prével R, Delmas Y, Guillotin V, Gruson D, Rivière E.
Complement Blockade Is a Promising Therapeutic Approach in a Subset of Critically Ill Adult Patients with Complement-Mediated Hemolytic Uremic Syndromes. Journal of Clinical Medicine. 2022; 11(3):790.
https://doi.org/10.3390/jcm11030790
Chicago/Turabian Style
Prével, Renaud, Yahsou Delmas, Vivien Guillotin, Didier Gruson, and Etienne Rivière.
2022. "Complement Blockade Is a Promising Therapeutic Approach in a Subset of Critically Ill Adult Patients with Complement-Mediated Hemolytic Uremic Syndromes" Journal of Clinical Medicine 11, no. 3: 790.
https://doi.org/10.3390/jcm11030790
APA Style
Prével, R., Delmas, Y., Guillotin, V., Gruson, D., & Rivière, E.
(2022). Complement Blockade Is a Promising Therapeutic Approach in a Subset of Critically Ill Adult Patients with Complement-Mediated Hemolytic Uremic Syndromes. Journal of Clinical Medicine, 11(3), 790.
https://doi.org/10.3390/jcm11030790